The key influencing features for predicting the risk of ED visits in the LGBM model were identified as recent ED visits, elapsed days since the initial diagnosis for lung cancer, the use of analgesics, and lymphocyte and albumin levels. The gene discussed is ALB; the disease is lung carcinoma.